BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20857135)

  • 41. [Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study].
    Reinhard T; Reis A; Kutkuhn B; Voiculescu A; Sundmacher R
    Klin Monbl Augenheilkd; 1999 Sep; 215(3):201-2. PubMed ID: 10528287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporeal photopheresis and mycophenolate mofetil.
    Schlaak M; Friedlein H; Kauer F; Renner R; Rogalski C; Simon JC
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):631-3. PubMed ID: 18410628
    [No Abstract]   [Full Text] [Related]  

  • 44. Minocycline in combination with mycophenolate mofetil in oral mucous membrane pemphigoid.
    Carrozzo M; Arduino PG; Baldovino S; Di Zenzo G; Salzano S; Calabresi V; Roccatello D
    Eur J Dermatol; 2008; 18(2):198-200. PubMed ID: 18424391
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil.
    Saidha S; Murphy S; Ronayne A; McCarthy P; Hennessy MJ; Counihan T
    J Neurol; 2010 Jun; 257(6):1035-8. PubMed ID: 20130897
    [No Abstract]   [Full Text] [Related]  

  • 46. Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma.
    Stratton RJ; Wilson H; Black CM
    Rheumatology (Oxford); 2001 Jan; 40(1):84-8. PubMed ID: 11157146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis.
    Worm M; Sterry W; Kolde G
    Br J Dermatol; 2000 Dec; 143(6):1324. PubMed ID: 11122046
    [No Abstract]   [Full Text] [Related]  

  • 48. Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.
    Liossis SN; Bounas A; Andonopoulos AP
    Rheumatology (Oxford); 2006 Aug; 45(8):1005-8. PubMed ID: 16490756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis.
    Gilmour E; Stewart DG
    Br J Dermatol; 2001 Feb; 144(2):397-400. PubMed ID: 11251582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mycophenolate mofetil for Crohn's disease.
    Atherton JC
    Gut; 2000 May; 46(5):740-1. PubMed ID: 10836856
    [No Abstract]   [Full Text] [Related]  

  • 53. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
    Bhat P; Cervantes-Castañeda RA; Doctor PP; Anzaar F; Foster CS
    Ocul Immunol Inflamm; 2009; 17(3):185-90. PubMed ID: 19585361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
    J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medication-associated lesions of the GI tract.
    Seminerio J; McGrath K; Arnold CA; Voltaggio L; Singhi AD
    Gastrointest Endosc; 2014 Jan; 79(1):140-50. PubMed ID: 24119504
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.
    Birnbaum F; Böhringer D; Sokolovska Y; Sundmacher R; Reinhard T
    Transplantation; 2005 Apr; 79(8):964-8. PubMed ID: 15849551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycophenolate mofetil and cough.
    Elli A; Aroldi A; Montagnino G; Tarantino A; Ponticelli C
    Transplantation; 1998 Aug; 66(3):409. PubMed ID: 9721817
    [No Abstract]   [Full Text] [Related]  

  • 59. Mycophenolate mofetil for lupus nephritis.
    McCune WJ
    N Engl J Med; 2005 Nov; 353(21):2282-4. PubMed ID: 16306526
    [No Abstract]   [Full Text] [Related]  

  • 60. Is mycophenolate mofetil a new alternative in the treatment of inflammatory bowel disease?
    Present DH
    Gut; 1999 May; 44(5):592-3. PubMed ID: 10205187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.